| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 04/11/2006 | US7026288 Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin |
| 04/11/2006 | US7026167 Systems and methods for the analysis of protein phosphorylation |
| 04/11/2006 | US7026149 for producing amino acids in microorganisms having enhanced or attenuated expression; genetic engineering |
| 04/11/2006 | US7026148 DAP-kinase related protein |
| 04/11/2006 | CA2242927C Process for chromatographic separation of peptides and nucleic acid, and new high affinity ion exchange matrix |
| 04/06/2006 | WO2006036119A1 Method and device for isoelectric focusing |
| 04/06/2006 | WO2006036003A1 Microparticle having, linked thereto, substance having biospecific affinity and use thereof |
| 04/06/2006 | WO2006035815A1 Method of producing partial peptide of enolase protein from plasmodium falciparum |
| 04/06/2006 | WO2006026470A3 Hiv immunostimulatory compositions |
| 04/06/2006 | US20060074227 Antibodies against PRO Polypeptides which may be overexpressed in tumors |
| 04/06/2006 | US20060074226 Pro9835 antibodies |
| 04/06/2006 | US20060074037 Producing/evaluating a protein/polypeptide (alpha-defensin) with increased antimicrobial activity and stability to effect chemotaxis of T-cells, neutrophil recruitment, or cytokine or interleukin-8 release; immunostimulants; respiratory system disorders; inflammatory bowel disease; viricides; cancer; HIV |
| 04/06/2006 | US20060073611 Immunoassay |
| 04/06/2006 | US20060073568 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073545 PRO polypeptides and chimeric polypeptides; may be drug target for tumors |
| 04/06/2006 | US20060073544 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073518 Method for selecting a candidate drug compound |
| 04/06/2006 | US20060070880 Methods and apparatus for manipulating separation media |
| 04/06/2006 | DE10240098B4 Verfahren zur Synthese und selektiven biokatalytischen Modifizierung von Peptiden, Peptidmimetika und Proteinen A process for the synthesis and selective biocatalytic modification of peptides, peptide mimetics and proteins |
| 04/06/2006 | DE102004054545A1 Änderung des Beladungszustandes von MHC-Molekülen Changing the load state of MHC molecules |
| 04/06/2006 | CA2582041A1 Recombinant human t2 rnase and uses thereof |
| 04/06/2006 | CA2581505A1 Srage mimetibody, compositions, methods and uses |
| 04/05/2006 | EP1642980A1 Modified proteins and methods of their production |
| 04/05/2006 | EP1642904A1 Protein achieving improved blocking efficiency |
| 04/05/2006 | EP1641942A2 Combinatorial nucleobase oligomers comprising universal base analogues and methods for making and using same |
| 04/05/2006 | EP1641819A1 Purification of her-2 variants |
| 04/05/2006 | EP1641814A1 New process for the production of melagatran |
| 04/05/2006 | EP1641813A2 Methods for obtaining molecules with reduced immunogenicity |
| 04/05/2006 | EP1641730A1 Recombined molecules and preparation thereof |
| 04/05/2006 | EP1641481A2 Formation of novel erythropoietin conjugates using transglutaminase |
| 04/05/2006 | EP1596667A4 Process for concentration of macromolecules |
| 04/05/2006 | EP1558644A4 A structured peptide scaffold for displaying turn libraries on phage |
| 04/05/2006 | EP1337549B1 Process for folding chemically synthesized polypeptides |
| 04/05/2006 | EP1042963B1 Granular sweetener |
| 04/05/2006 | EP0991660B8 DEUTERATED and undeuterated CYCLOSPORINE ANALOGS AND THEIR USE AS IMMUNOMODULATING AGENTS |
| 04/05/2006 | CN1756766A Dispersing agents in nanocomposites |
| 04/05/2006 | CN1756762A Method of generating metal chelating affinity ligands |
| 04/05/2006 | CN1756761A Target recognizing binding agents |
| 04/05/2006 | CN1249080C Electrophoresis system |
| 04/05/2006 | CN1249079C Process for partitioning of proteins |
| 04/05/2006 | CN1249078C Process for folding chemically synthesized polypeptides |
| 04/05/2006 | CN1248735C Preparing method and usage of cardiotoxin |
| 04/05/2006 | CA2523089A1 Methods for separation of polymeric compounds |
| 04/04/2006 | US7024312 Genetic engineering; libraries; computer analyzing |
| 04/04/2006 | US7024311 Computer-aided method for the provision, identification and description of molecules capable of exhibiting a desired behavior, more particularly in the pharmaceutical sector, and molecules obtained by said method |
| 04/04/2006 | US7022822 Purification process for obtaining the human urinary gonadotropins follicle-stimulating hormone (FSH) and/or luteinizing hormone (LH) using ion exchange resins; obtained FSH and LH are absolutely free of foreign contaminants derived from the use of biological reagents or chromatography dyes |
| 04/04/2006 | US7022821 Tumor Antigen Derived Gene-15 (TADG-15); a detectably labeled antibody specific for the TADG-15 protein which has a molecular size of 100 kDa and comprises CUB, LDLR and serine protease domains; useful in the diagnosis or treatment of breast and ovarian cancer in particular |
| 04/04/2006 | US7022817 Nucleotide sequence codin polypeptide for use in the diagnosis and treatment of nervous system and cancer disorders |
| 04/04/2006 | US7022814 polypeptide fragment of a viral protein selected from HIV-1 Bru, HIV-1 Mal, HIV-1 Eli, HIV-2 ROD, or SIV-1 MAC made by transforming a host cell with a vector that was derived from an amplified sequence made using primers that are insensitive to variations in the genomes of different HIV and SIV isolates |
| 04/04/2006 | US7022673 Generation of biocompatible active macromolecules with amplified half-life; obtain macromolecule, couple to polymer, recover macromolecule |
| 04/04/2006 | US7022672 Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitor |
| 04/04/2006 | US7022500 Humanized immunoglobulins |
| 04/04/2006 | US7022491 Method for determining molecule—molecule interaction analysis |
| 04/04/2006 | US7022484 Methods for treating neuropathological states and neurogenic inflammatory states and methods for identifying compounds useful therein |
| 04/04/2006 | US7022328 Therapeutic and diagnostic compositions |
| 04/04/2006 | US7022322 Comprises ligand for human immunoglobulin for immunoapheresis, which mimicks sequence of an adrenergic receptor structure |
| 04/04/2006 | US7022310 Deuterated hydrogen in protein, radioactive carbon or nitrogen; bioassay of accurate analyzing the structure of the target high molecular weight protein; producing stable isotope-labeled fumaric acid, tartaric acid through esterification, oxidation, hydrolysis; chemical peptide synthesis |
| 04/04/2006 | US7022309 Targeting molecule linked to an imaging agent |
| 03/30/2006 | WO2006034496A2 Methods and materials for optimization of electronic transportation and hybridization reactions |
| 03/30/2006 | WO2006033878A1 Process for preparing macrocyclic hcv protease inhibitors |
| 03/30/2006 | WO2006033851A1 Ring-closing metathesis process in supercritical fluid |
| 03/30/2006 | WO2006032499A1 Purification process for bacterial cytolysin |
| 03/30/2006 | WO2006032457A1 Peptide cyclisation |
| 03/30/2006 | WO2006001832A3 Selective incorporation of 5-hyroxytryptophan into proteins in mammalian cells |
| 03/30/2006 | WO2005121169A3 Apoptosis-inducing polypeptides |
| 03/30/2006 | WO2004063714A3 Methods for the detection, analysis and isolation of nascent proteins |
| 03/30/2006 | US20060069519 Method for predicting protein-protein interactions |
| 03/30/2006 | US20060069244 Method and system for solubilizing protein |
| 03/30/2006 | US20060068502 Method for determining the presence of an analyte; providing in a single molecule: a molecular scaffold, a first label an RET donor and a second label of an RET acceptor bound to the molecular scaffold, a molecular recognition domain; detecting the optical signal |
| 03/30/2006 | US20060068480 Polypeptides and polypeptide analogues |
| 03/30/2006 | US20060068423 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/30/2006 | US20060068413 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/30/2006 | US20060068404 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/30/2006 | US20060067884 for radiolabeling proteins, peptides and ligands with therapeutic radioisotopes such that these radiolabeled agents may be administered directly to patients without the need for additional purification; for the treatment of cancer |
| 03/30/2006 | US20060065531 Current and voltage is applied to a location of the device to effect electrophoretic transportation of the nucleic acid towards the location; nucleic acid is then hybridized to a nucleic probed located at the location; reducing agent in the low conductivity buffer may also be acting as a chaotropic agent |
| 03/30/2006 | US20060065530 Capillary electrophoresis probes and method |
| 03/30/2006 | US20060065529 Polyelectrolyte film of interpenetrating network of positively charged copolymer and negatively charged copolymer; having both repeating units with pka of 3-9 and repeating units with pka more than 9 or less than 3 |
| 03/30/2006 | US20060065528 Nanostructured devices for separation and analysis |
| 03/30/2006 | DE19911771B4 LHRH-Antagonist, Verfahren zu seiner Herstellung und seiner Verwendung LHRH antagonist, process for its preparation and its use |
| 03/30/2006 | DE102004044429A1 Verfahren zur Entfernung von Fibronektin aus Plasmafraktionen A method of removing fibronectin from plasma fractions |
| 03/30/2006 | DE102004044421A1 Herstellung eines von Willebrand Faktor-Präparates mit hoher spezifischer Aktivität Production of a von Willebrand factor preparation of high specific activity |
| 03/30/2006 | DE102004044419A1 Herstellung eines von Willebrand Faktor-Präparates unter Verwendung von Hydroxylapatit Production of a von Willebrand factor preparation using hydroxyapatite |
| 03/30/2006 | CA2581215A1 Peptide cyclisation |
| 03/30/2006 | CA2580881A1 Use of microproteins as tryptase inhibitors |
| 03/30/2006 | CA2580113A1 Purification process for bacterial cytolysin |
| 03/30/2006 | CA2579124A1 Methods and materials for optimization of electronic transportation and hybridization reactions |
| 03/30/2006 | CA2578428A1 Ring-closing metathesis process in supercritical fluid |
| 03/30/2006 | CA2577831A1 Process for preparing macrocyclic hcv protease inhibitors |
| 03/29/2006 | EP1639141A2 Methods for treating lentivirus infections |
| 03/29/2006 | EP1639085A2 Modified human acid sphingomyelinase having increased activity, and methods for making the same |
| 03/29/2006 | EP1638990A1 Removal of lipopolysaccharides from protein- lipopolysaccharide complexes by nonflammable solvents |
| 03/29/2006 | EP1638989A2 Method and apparatus for continuous large-scale radiolabeling of proteins |
| 03/29/2006 | EP1638662A2 Conjugates of magnetic polymer particles and carboxymethylated aspartic acid |
| 03/29/2006 | EP1638443A2 Isoforms of brain natriuretic peptide |
| 03/29/2006 | EP1433743B1 Method for preparing cobalt-protein complex |
| 03/29/2006 | EP1079847B1 Osteoporosis treatment |
| 03/29/2006 | EP1064300A4 Peptide turn mimetics |
| 03/29/2006 | EP1007554B1 Oil bodies and associated proteins as affinity matrices |
| 03/29/2006 | CN1753725A Chemical processes by the use of combinations of solvents capable of taking reversibly homogeneously mixed state and separated state dependently on temperature |
| 03/29/2006 | CN1753724A Peptide mediated synthesis of metallic and magnetic materials |